• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主特异性治疗对小鼠腹腔巨噬细胞吞噬克氏锥虫血液型的影响。

Effect of the host specific treatment in the phagocytosis of Trypanosoma cruzi blood forms by mouse peritoneal macrophages.

作者信息

Lages-Silva E, Filardi L S, Brener Z

机构信息

Centro de Pesquisas René Rachou, FIOCRUZ, Belo Horizonte, MG, Brasil.

出版信息

Mem Inst Oswaldo Cruz. 1990 Oct-Dec;85(4):401-5. doi: 10.1590/s0074-02761990000400003.

DOI:10.1590/s0074-02761990000400003
PMID:2152191
Abstract

Single doses of drugs active against Trypanosoma cruzi (megazol, nifurtimox and benznidazole) induce a rapid clearance of the blood parasites in experimentally infected mice. Furthermore, the in vitro phagocytosis and intracellular destruction by mouse peritoneal macrophage of blood forms collected from the treated animals is strongly enhanced as compared with parasites from untreated controls. The uptake of the blood forms by macrophages is significantly higher with megazol than with benznidazole and nifurtimox, a finding that concurs with data showing that megazol is also the most active compound in the living host. The possibility that macrophages participate in a synergic effect between the host immune response and chemotherapeutic effect is discussed.

摘要

单剂量的抗克氏锥虫活性药物(美唑、硝呋莫司和苯硝唑)可使实验感染小鼠体内的血液寄生虫迅速清除。此外,与未治疗对照组的寄生虫相比,从经治疗动物采集的血液型态被小鼠腹腔巨噬细胞的体外吞噬作用和细胞内破坏作用显著增强。巨噬细胞对血液型态的摄取,美唑组比苯硝唑组和硝呋莫司组显著更高,这一发现与表明美唑在活体宿主中也是最具活性化合物的数据相符。文中讨论了巨噬细胞参与宿主免疫反应与化疗效果之间协同作用的可能性。

相似文献

1
Effect of the host specific treatment in the phagocytosis of Trypanosoma cruzi blood forms by mouse peritoneal macrophages.宿主特异性治疗对小鼠腹腔巨噬细胞吞噬克氏锥虫血液型的影响。
Mem Inst Oswaldo Cruz. 1990 Oct-Dec;85(4):401-5. doi: 10.1590/s0074-02761990000400003.
2
Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.针对克氏锥虫的噻唑类化合物的结构设计、合成及药理学评价
Eur J Med Chem. 2017 Dec 1;141:346-361. doi: 10.1016/j.ejmech.2017.09.047. Epub 2017 Sep 22.
3
Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.低剂量苯硝唑治疗可使寄生虫清除,并减轻高毒力克氏锥虫感染实验模型中的心脏炎症反应。
Int J Parasitol Drugs Drug Resist. 2015 Dec 12;6(1):12-22. doi: 10.1016/j.ijpddr.2015.12.001. eCollection 2016 Apr.
4
Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.评价联合使用苯硝唑、硝呋替莫、泊沙康唑或两性霉素 B 脂质体治疗感染克氏锥虫株的小鼠的疗效。
Int J Antimicrob Agents. 2012 Dec;40(6):527-32. doi: 10.1016/j.ijantimicag.2012.08.002. Epub 2012 Oct 12.
5
Evaluation of thiosemicarbazones and semicarbazones as potential agents anti-Trypanosoma cruzi.评价硫代卡巴肼和卡巴肼作为潜在的抗克氏锥虫药物。
Exp Parasitol. 2011 Dec;129(4):381-7. doi: 10.1016/j.exppara.2011.08.019. Epub 2011 Sep 14.
6
Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study.硝基杂环类药物改善克氏锥虫感染疗效的时间和剂量依赖性评价:一项临床前研究。
Biochem Pharmacol. 2018 Feb;148:213-221. doi: 10.1016/j.bcp.2018.01.005. Epub 2018 Jan 5.
7
Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.克氏锥虫 TcV 临床分离株的表型多样性和药物敏感性。
PLoS One. 2018 Sep 5;13(9):e0203462. doi: 10.1371/journal.pone.0203462. eCollection 2018.
8
Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.喷他脒在体外拮抗苯硝唑的作用,且在体内缺乏协同作用:关于多胺转运作为抗克氏锥虫靶点的意义。
Exp Parasitol. 2016 Dec;171:23-32. doi: 10.1016/j.exppara.2016.10.007. Epub 2016 Oct 8.
9
Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.新型苯硝唑溶液在克氏锥虫实验性感染期间的疗效
Parasitol Int. 2013 Feb;62(1):79-81. doi: 10.1016/j.parint.2012.09.001. Epub 2012 Sep 10.
10
In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.酸浆浓缩乙醇提取物对克氏锥虫的体外和体内抗寄生虫活性
Phytomedicine. 2015 Oct 15;22(11):969-74. doi: 10.1016/j.phymed.2015.07.004. Epub 2015 Jul 29.

引用本文的文献

1
Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group.硝基咪唑类药物的遗传毒性和致突变性研究:揭开与硝基的关键关系之谜
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):492-9. doi: 10.1590/0074-02760140248. Epub 2015 May 26.
2
Synthesis and trypanocidal activity of novel 2,4,5-triaryl-N-hydroxylimidazole derivatives.新型 2,4,5-三芳基-N-羟基亚咪唑衍生物的合成与杀锥虫活性。
Molecules. 2013 Mar 15;18(3):3445-57. doi: 10.3390/molecules18033445.
3
Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies.
潜在抗克氏锥虫候选物的筛选:体外和体内研究
Open Med Chem J. 2011;5:21-30. doi: 10.2174/1874104501105010021. Epub 2011 Mar 9.
4
In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruzi.1,3,4-噻二唑-2-芳基腙衍生物对克氏锥虫的体外和体内活性。
Antimicrob Agents Chemother. 2010 May;54(5):2023-31. doi: 10.1128/AAC.01241-09. Epub 2010 Mar 15.
5
Chagas' disease: an update on immune mechanisms and therapeutic strategies.恰加斯病:免疫机制和治疗策略的最新进展。
J Cell Mol Med. 2010 Jun;14(6B):1373-84. doi: 10.1111/j.1582-4934.2010.01007.x. Epub 2010 Jan 11.
6
Absence of CD4+ T lymphocytes, CD8+ T lymphocytes, or B lymphocytes has different effects on the efficacy of posaconazole and benznidazole in treatment of experimental acute Trypanosoma cruzi infection.CD4+ T淋巴细胞、CD8+ T淋巴细胞或B淋巴细胞的缺失对泊沙康唑和苯硝唑治疗实验性急性克氏锥虫感染的疗效有不同影响。
Antimicrob Agents Chemother. 2009 Jan;53(1):174-9. doi: 10.1128/AAC.00779-08. Epub 2008 Nov 10.